GGrantIndex
Sort

65,743 grants matching single cell sequencing

International Genetic Epidemiology of Oral Clefts

$692,820
Terri H Beaty · Johns Hopkins University · R01 · FY2010 · DE

Compartmentalized CSF viral escape and the CNS HIV reservoir

$692,820
Richard W Price · University Of California, San Francisco · R01 · FY2017 · NS

Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics

$692,783
David R Liu · Broad Institute, Inc. · R35 · FY2018 · GM

Mechanisms regulating functional heterogeneity of subcutaneous adipose tissues in women

$692,779
Susan K Fried · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK

Pulmonary Artery Endothelial Cell Endotypes and the Role of Anoikis Resistance in Pulmonary Hypertension

$692,768
Corey E Ventetuolo · Rhode Island Hospital · R01 · FY2025 · HL

Linking Human TB Genetic Susceptibility Loci to Granuloma Biology

$692,701
David M. Tobin · Duke University · R01 · FY2022 · AI

EDGE CMT: RUI: Roles of Toxin-Antitoxin Systems in Biofilm Formation and Horizontal Gene Transfer in the genus Variovorax

$692,668
Paul Orwin · University Of The Pacific · · FY2021 · BIO

EDGE CMT: RUI: Roles of Toxin-Antitoxin Systems in Biofilm Formation and Horizontal Gene Transfer in the genus Variovorax

$692,668
Paul Orwin · University Enterprises Corporation At Csusb · · FY2021 · BIO

Linking Human TB Genetic Susceptibility Loci to Granuloma Biology

$692,654
David M. Tobin · Duke University · R01 · FY2023 · AI

Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function

$692,649
Joseph C Wu · Stanford University · R01 · FY2020 · HL

Research Project 3: siRNA Therapy and Small Molecule Combination Treatment for Filoviruses

$692,621
Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2019 · AI

Restoring Immune Balance in Hiddradenitis Suppurativa

$692,612
Michael David Rosenblum · University Of California, San Francisco · R01 · FY2022 · AR

Linking Human TB Genetic Susceptibility Loci to Granuloma Biology

$692,606
David M. Tobin · Duke University · R01 · FY2024 · AI

Cancer Immune-Interception for Lynch Syndrome

$692,579
Eduardo Vilar Sanchez · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells

$692,567
Carl D Novina · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Contributions of aberrant synaptic protein monoaminylation to opiate use disorder

$692,516
Ian S. Maze · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DA

Molecular Analysis Of Human Hereditary Deafness

$692,498
Andrew J. Griffith · Deafness & Other Communication Disorders · Z01 · FY2007 · DC

Assembly Forces And Recognition Reactions

$692,466
Donald Rau · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD

Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk

$692,449
Muredach P Reilly · Columbia University Health Sciences · R01 · FY2023 · HL

Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics

$692,434
David R Liu · Broad Institute, Inc. · R35 · FY2019 · GM

Multi-cellular interactions defining the human brain metastatic niche

$692,427
Benjamin Izar · Columbia University Health Sciences · R01 · FY2025 · CA

Heterogeneity of Satellite Cell Populations Play a Role in Improvements in PAD after Exercise Therapy

$692,423
Laura Marie Hansen · Emory University · R01 · FY2023 · HL

Effects of maternal e-cigarette aerosol exposure on nicotine's addiction-related behavioral and neurobiological effects in offspring

$692,419
Mark G Lesage · Hennepin Healthcare Research Institute · R01 · FY2025 · DA

Single-cell resolution analysis of chromatin accessibility and gene expression changes in a model of drug addiction

$692,366
Francesca Telese · University Of California, San Diego · U01 · FY2023 · DA

Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis

$692,347
Jake Jinkun Chen · Tufts University Boston · R01 · FY2023 · DE